Eli Lilly said the obesity medicine, which helped adults in clinical studies lose about 20% of their body weight, will be available in the U.S. by the end of the year. The list price will be $1,060.
On a trip back to her parents' native country, a writer rediscovers what makes it different. The urban design, and a culture that values longevity, make good health come al lot more naturally.
The annual Trust for America’s Health report finds the CDC's budget has risen just 6% in the last decade and needs a 26% boost to help fund emergency public health programs in Georgia and the rest of the nation.
There's already a huge demand for existing weight-loss drugs, so the new medication is highly anticipated. Obesity affects an estimated 650 million adults globally.
Maria Caprigno was one of the youngest people in the U.S. to get the surgery. As parents and doctors grapple with the obesity treatment for teens, Caprigno cites the long-term benefits.
Many eating disorder specialists oppose the new guidance's focus on weight loss and BMI, and say it minimizes the risk of disordered eating and will perpetuate deep-rooted, damaging stigmas.
As the marketing of soda and fast food ramps up around the world, the companies involved forge partnerships to help the poor. The new book 'Junk Food Politics' casts a critical eye at their efforts.
Most doctors get little training in the science of obesity or how to counsel people with the disease. As a result, many patients experience stigma in the exam room.
The new weight-loss drugs can be life-changing for people facing health conditions worsened by obesity, but price and spotty insurance coverage may keep them out of reach.
Instead of "watchful waiting," the American Academy of Pediatrics now recommends intensive lifestyle and behavior therapy for young kids, and for older children, medication.
The State of Obesity report from Trust for America’s Health looks at factors like poverty, access to healthy food and walkability in communities. It found Georgia made slight improvements in obesity rates since last year’s report.
Clinical trials show Wegovy triples the average weight loss seen with other drugs. Whether it will reach many patients largely depends on whether insurers decide to cover it.
In the U.S. South — home to nine of the nation's 12 heaviest states — obesity is playing a role not only in COVID-19 outcomes but in the calculus of the vaccination rollout.
A new report describes a region where hunger and malnutrition are sharply increasing — and only likely to get worse as COVID-19 pushes more people into poverty.
